Syndax Pharmaceuticals Ownership | Who Owns Syndax Pharmaceuticals?
Syndax Pharmaceuticals Ownership Summary
Syndax Pharmaceuticals is owned by 117.29% institutional investors, 1.28% insiders. Blackrock funding, inc. /de is the largest institutional shareholder, holding 9.99% of SNDX shares. Vanguard Health Care Inv is the top mutual fund, with 3.50% of its assets in Syndax Pharmaceuticals shares.
SNDX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Syndax Pharmaceuticals | 117.29% | 1.28% | -18.57% |
| Sector | Healthcare Stocks | 42.52% | 10.81% | 46.67% |
| Industry | Biotech Stocks | 45.18% | 10.75% | 44.06% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock funding, inc. /de | 8.63M | 9.99% | $132.70M |
| Kynam capital management, lp | 8.52M | 9.87% | $131.08M |
| Blackrock | 7.91M | 9.28% | $162.33M |
| Goldman sachs group | 5.49M | 6.35% | $84.41M |
| Vanguard group | 5.14M | 5.95% | $79.06M |
| Point72 asset management | 4.26M | 4.93% | $65.46M |
| State street | 3.85M | 4.46% | $59.29M |
| Eversept partners, lp | 3.47M | 4.02% | $53.34M |
| Adage capital partners gp | 3.31M | 3.84% | $50.95M |
| Kingdon capital management | 2.50M | 2.90% | $38.46M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Kynam capital management, lp | 8.52M | 9.76% | $131.08M |
| Lion point capital, lp | 55.00K | 4.81% | $846.17K |
| Kingdon capital management | 2.50M | 4.77% | $38.46M |
| Catalio capital management, lp | 1.61M | 4.59% | $24.84M |
| Aisling capital management lp | 1.32M | 4.44% | $20.27M |
| Stempoint capital lp | 1.37M | 4.21% | $21.02M |
| Eversept partners, lp | 3.47M | 3.68% | $53.34M |
| Prosight management, lp | 1.00M | 3.60% | $15.44M |
| Bioimpact capital | 1.38M | 3.46% | $21.16M |
| Knott david m jr | 428.00K | 2.66% | $6.58M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Point72 asset management | 4.26M | 0.11% | 2.13M |
| Adage capital partners gp | 3.31M | 0.08% | 1.88M |
| Bioimpact capital | 1.38M | 3.46% | 1.38M |
| Nuveen | 1.48M | 0.01% | 1.21M |
| Soleus capital management | 2.01M | 1.56% | 920.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Avoro capital advisors | - | - | -2.27M |
| Orbimed advisors | - | - | -1.93M |
| Bvf inc/il | - | - | -1.88M |
| Blackrock funding, inc. /de | 8.63M | 0.00% | -1.83M |
| Balyasny asset management | 126.14K | 0.00% | -1.69M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Bioimpact capital | 1.38M | 3.46% | 1.38M | $21.16M |
| Apis capital advisors | 638.00K | 2.17% | 638.00K | $9.82M |
| Ikarian capital | 333.73K | 0.52% | 333.73K | $5.13M |
| Canada pension plan investment board | 229.60K | 0.00% | 229.60K | $3.53M |
| Sector gamma as | 210.81K | 0.80% | 210.81K | $3.24M |
Sold Out
| Holder | Change |
|---|---|
| Tfc financial management | -1.00 |
| Nelson, van denburg & campbell wealth management group | -13.00 |
| Riggs asset managment | -26.00 |
| Svb wealth | -27.00 |
| Stephens consulting | -30.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 238 | 5.78% | 101,267,970 | 8.78% | 117 | 1.01% | 123 | 6.03% | 69 | 13.11% |
| Jun 30, 2025 | 232 | - | 101,730,191 | 1.68% | 117 | 0.86% | 116 | -3.33% | 65 | 1.56% |
| Mar 31, 2025 | 233 | 2.19% | 100,944,775 | 2.97% | 117 | 0.90% | 119 | -7.03% | 65 | 10.17% |
| Dec 31, 2024 | 216 | -5.68% | 91,955,124 | 3.35% | 107 | 0.99% | 119 | -4.03% | 58 | -1.69% |
| Sep 30, 2024 | 225 | 11.39% | 88,858,869 | 1.79% | 104 | 0.99% | 121 | 10.00% | 59 | -3.28% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Health Care Inv | 2.99M | 3.50% | - |
| Vanguard US Total Market Shares ETF | 2.60M | 3.01% | 4.69K |
| Vanguard Total Stock Mkt Idx Inv | 2.56M | 2.98% | -56.87K |
| iShares Russell 2000 ETF | 2.06M | 2.39% | - |
| SPDR® S&P Biotech ETF | 1.54M | 1.78% | 3.43K |
| Eventide Healthcare & Life Sciences I | 1.41M | 1.64% | 236.02K |
| Franklin Biotechnology Discv A(acc)USD | 1.02M | 1.18% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 935.83K | 1.09% | -408.69K |
| Belfius Equities Cure C Cap | 925.33K | 1.07% | 250.25K |
| Fidelity Small Cap Index | 854.73K | 0.99% | 23.11K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 08, 2025 | Metzger Michael A | Chief Executive Officer | Sell | $2.58M |
| Aug 14, 2025 | Podlesak Dennis | - | Sell | $272.52K |
| Aug 15, 2025 | Podlesak Dennis | - | Sell | $298.41K |
| Aug 18, 2025 | Podlesak Dennis | - | Sell | $304.17K |
| Jul 16, 2025 | Goldan Keith A. | Chief Financial Officer | Sell | $12.03K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | 6 |
| 2025 Q2 | 4 | - |
| 2025 Q1 | - | 4 |
| 2024 Q2 | 1 | - |
| 2024 Q1 | - | - |
SNDX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools